The Latest Headlines at Ticker Report
Insider Buying: LCNB (NASDAQ:LCNB) Director Acquires $19,790.00 in Stock
LCNB Corporation (NASDAQ:LCNB – Get Free Report) Director Anne Krehbiel acquired 1,000 shares of LCNB stock in a transaction on Monday, October 26th. The stock was acquired at an average cost of $19.79 per share, for a total... More of this article »
Silgan (NYSE:SLGN) Stock Price Target Raised at Royal Bank Of Canada
Silgan (NYSE:SLGN – Free Report) had its price target increased by Royal Bank Of Canada from $47.00 to $48.00 in a research report released on Friday,Benzinga reports. The brokerage currently has an outperform rating on the industrial... More of this article »
L3Harris Technologies (NYSE:LHX) Given New $295.00 Price Target at Royal Bank Of Canada
L3Harris Technologies (NYSE:LHX – Free Report) had its price objective upped by Royal Bank Of Canada from $265.00 to $295.00 in a report released on Friday,Benzinga reports. Royal Bank Of Canada currently has a sector perform... More of this article »-logo.png){kind=logo}
Maplebear (NASDAQ:CART) Stock Bumped Down to “Market Perform” by Sanford C. Bernstein
Sanford C. Bernstein downgraded shares of Maplebear (NASDAQ:CART – Free Report) from an outperform rating to a market perform rating in a report published on Friday morning,Benzinga reports. They currently have $65.00 target... More of this article »
Oppenheimer & Co. Inc. Purchases New Stake in iShares U.S. Technology ETF $IYW
Oppenheimer & Co. Inc. acquired a new position in shares of iShares U.S. Technology ETF (NYSEARCA:IYW – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission.... More of this article »
Park Avenue Securities LLC Makes New Investment in Invesco BulletShares 2033 Corporate Bond ETF $BSCX
Park Avenue Securities LLC purchased a new stake in Invesco BulletShares 2033 Corporate Bond ETF (NASDAQ:BSCX – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission... More of this article »
iShares iBoxx $ Investment Grade Corporate Bond ETF $LQD Shares Sold by Kingswood Wealth Advisors LLC
Kingswood Wealth Advisors LLC reduced its position in iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSEARCA:LQD – Free Report) by 66.6% in the 3rd quarter, according to the company in its most recent disclosure with the... More of this article »
57,839 Shares in Dimensional National Municipal Bond ETF $DFNM Bought by Park Avenue Securities LLC
Park Avenue Securities LLC purchased a new stake in Dimensional National Municipal Bond ETF (NYSEARCA:DFNM – Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The firm purchased... More of this article »
STUB $STUB Stock Purchased by Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. grew its position in shares of STUB (NYSE:STUB – Free Report) by 46.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.... More of this article »
13,012 Shares in SPDR S&P Aerospace & Defense ETF $XAR Bought by Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. acquired a new stake in SPDR S&P Aerospace & Defense ETF (NYSEARCA:XAR – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission.... More of this article »
77,675 Shares in First Trust Senior Loan ETF $FTSL Bought by Park Avenue Securities LLC
Park Avenue Securities LLC bought a new position in First Trust Senior Loan ETF (NASDAQ:FTSL – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.... More of this article »
63,028 Shares of SPDR Portfolio Emerging Markets ETF $SPEM Purchased by Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. purchased a new position in shares of SPDR Portfolio Emerging Markets ETF (NYSEARCA:SPEM – Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange... More of this article »
DexCom (NASDAQ:DXCM) Given New $120.00 Price Target at Barclays
DexCom (NASDAQ:DXCM – Free Report) had its price objective raised by Barclays from $115.00 to $120.00 in a research note published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical device... More of this article »